LEVY RAPHI (Chief Financial Officer) sold 11.8% of their position (17.50K shares) of ALPHA TAU MEDICAL LTD. on the open market
Open‑market sale worth $167.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/25/2026ACC: 0001213900-26-071830
Officer· Chief Financial Officer
Since Mar 2026
-17.50K
Net shares
Net seller
$167.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
17.50K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−15K
Price / share
$9.47
Trade value
$142.05K
% of position
10.2%
6/23/2026
147.68K→132.68K
Ordinary Shares
Direct
Shares
−2.50K
Price / share
$10.00
Trade value
$25K
% of position
1.9%
6/23/2026
132.68K→130.18K
Total
Net shares
−17.50K
Net value
-$167.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/23/2026 | S · Sale | −15K | $9.47 | $142.05K | 10.2% | 147.68K | 132.68K |
| Ordinary Shares Direct | 6/23/2026 | S · Sale | −2.50K | $10.00 | $25K | 1.9% | 132.68K | 130.18K |
| Total | −17.50K | -$167.05K | ||||||
Derivative Transactions0
No derivative transactions reported